01 14Opdivo
02 4Opdivo
03 1Opdivo (Domestic + Overseas)
04 1Opdualag
05 2Opdualag
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 6,992
2019 Revenue in Millions : 7,204
Growth (%) : -3
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 907
2019 Revenue in Millions : 827
Growth (%) : 10
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 7,523
2020 Revenue in Millions : 6,992
Growth (%) : 8
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 908
2020 Revenue in Millions : 870
Growth (%) : 12
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 8,249
2021 Revenue in Millions : 7,523
Growth (%) : 10
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 1,050
2021 Revenue in Millions : 908
Growth (%) : 16
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 252
2021 Revenue in Millions : 0
Growth (%) : New Launch in 2022
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 627
2022 Revenue in Millions : 252
Growth (%) : 149
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 9,009
2022 Revenue in Millions : 8,249
Growth (%) : 9
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 1,001
2022 Revenue in Millions : 1,050
Growth (%) : 8
